These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
226 related items for PubMed ID: 18192850
1. A comparison of atenolol and nebivolol in isolated systolic hypertension. Dhakam Z, Yasmin, McEniery CM, Burton T, Brown MJ, Wilkinson IB. J Hypertens; 2008 Feb; 26(2):351-6. PubMed ID: 18192850 [Abstract] [Full Text] [Related]
3. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers. Polónia J, Barbosa L, Silva JA, Bertoquini S. Blood Press Monit; 2010 Oct; 15(5):235-9. PubMed ID: 20577082 [Abstract] [Full Text] [Related]
5. Effects of nebivolol and atenolol on central aortic pressure in hypertensive patients: a multicenter, randomized, double-blind study. Redón J, Pascual-Izuel JM, Rodilla E, Vicente A, Oliván J, Bonet J, Torguet JP, Calaforra O, Almirall J. Blood Press; 2014 Jun; 23(3):181-8. PubMed ID: 24059690 [Abstract] [Full Text] [Related]
8. Nitric-oxide-mediated relaxations in salt-induced hypertension: effect of chronic beta1 -selective receptor blockade. Cosentino F, Bonetti S, Rehorik R, Eto M, Werner-Felmayer G, Volpe M, Lüscher TF. J Hypertens; 2002 Mar; 20(3):421-8. PubMed ID: 11875309 [Abstract] [Full Text] [Related]
9. Comparison of effects on systolic and diastolic left ventricular function of nebivolol versus atenolol in patients with uncomplicated essential hypertension. Kamp O, Sieswerda GT, Visser CA. Am J Cardiol; 2003 Aug 01; 92(3):344-8. PubMed ID: 12888152 [Abstract] [Full Text] [Related]
10. Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: results of a double-blind randomized multicentre trial. Grassi G, Trevano FQ, Facchini A, Toutouzas T, Chanu B, Mancia G. Blood Press Suppl; 2003 Dec 01; 2():35-40. PubMed ID: 14761075 [Abstract] [Full Text] [Related]
11. The combination of nebivolol plus pravastatin is associated with a more beneficial metabolic profile compared to that of atenolol plus pravastatin in hypertensive patients with dyslipidemia: a pilot study. Rizos E, Bairaktari E, Kostoula A, Hasiotis G, Achimastos A, Ganotakis E, Elisaf M, Mikhailidis DP. J Cardiovasc Pharmacol Ther; 2003 Jun 01; 8(2):127-34. PubMed ID: 12808486 [Abstract] [Full Text] [Related]
12. Effects of nebivolol and atenolol on small arteries and microcirculatory endothelium-dependent dilation in hypertensive patients undergoing isometric stress. Arosio E, De Marchi S, Prior M, Zannoni M, Lechi A. J Hypertens; 2002 Sep 01; 20(9):1793-7. PubMed ID: 12195121 [Abstract] [Full Text] [Related]
17. Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetes. Fogari R, Zoppi A, Lazzari P, Mugellini A, Lusardi P, Preti P, Van Nueten L, Vertommen C. J Hum Hypertens; 1997 Nov 01; 11(11):753-7. PubMed ID: 9416986 [Abstract] [Full Text] [Related]